Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > CEACAM-5

CEACAM-5

Brief Information

Name:Carcinoembryonic antigen related cell adhesion molecule 5
Target Synonym:CEA Cell Adhesion Molecule 5,CEACAM5,Meconium antigen 100,CEA,Carcinoembryonic Antigen Related Cell Adhesion Molecule 5,Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5,Carcinoembryonic Antigen,CD66e Antigen,CD66e
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:11
Lastest Research Phase:Phase 3 Clinical

Product ListCompare or Buy

Cat. No. Species Product Description Structure Purity Feature
CE5-R52H3 Rhesus macaque Rhesus macaque CEACAM-5 / CD66e Protein, His Tag (MALS verified)
CE5-R52H3-structure
CE5-R52H3-sds
CE5-H82E4 Human Biotinylated Human CEACAM-5 / CD66e (593-675) Protein, His,Avitag™ (MALS verified)
CE5-H82E4-structure
CE5-H82E4-sds
CE5-H82E3 Human Biotinylated Human CEACAM-5 / CD66e (499-685) Protein, His,Avitag™ (MALS verified)
CE5-H82E3-structure
CE5-H82E3-sds
MBS-C014 Human ActiveMax® Human CEACAM-5 / CD66e μBeads, premium grade (for cells)
SCCHO-ATP081 Human CHO/Human CEACAM5 Stable Cell Line Development Service
CE5-H52H8 Human Human CEACAM-5 / CD66e (499-685) Protein, His Tag (MALS verified)
CE5-H52H8-structure
CHEK-ATP083 Human HEK293/Human CEACAM5 Stable Cell Line
CE5-C5257 Cynomolgus Cynomolgus CEACAM-5 / CD66e Protein, Llama IgG2b Fc Tag, low endotoxin (MALS verified)
CE5-C5257-structure
CE5-C5257-sds
CE5-H5259 Human Human CEACAM-5 Protein, Llama IgG2b Fc Tag, low endotoxin (MALS verified)
CE5-H5259-structure
CE5-H5259-sds
CE5-C82E6 Cynomolgus Biotinylated Cynomolgus CEACAM-5 / CD66e Protein, His,Avitag™ (MALS verified)
CE5-C82E6-structure
CE5-C82E6-sds
CE5-H82F6 Human Biotinylated Human CEACAM-5 / CD66e Protein, Fc,Avitag™, premium grade
CE5-H82F6-structure
CE5-H82F6-sds
CE5-HF255 Human FITC-Labeled Human CEACAM-5 / CD66e Protein, Fc Tag
CE5-HF255-structure
CE5-HF255-sds
CE5-C52H5 Cynomolgus Cynomolgus CEACAM-5 / CD66e Protein, His Tag (MALS verified)
CE5-C52H5-structure
CE5-C52H5-sds
CE5-H5253 Human Human CEACAM-5 Protein, Fc Tag (HPLC verified)
CE5-H5253-structure
CE5-H5253-sds
CE5-H5253-hplc
CE5-M52H3 Mouse Mouse CEACAM-5 Protein, His Tag
CE5-M52H3-structure
CE5-M52H3-sds
CE5-M5253 Mouse Mouse CEACAM-5 Protein, Fc Tag (MALS verified)
CE5-M5253-structure
CE5-M5253-sds
CE5-HF254 Human FITC-Labeled Human CEACAM-5 / CD66e Protein, His Tag (MALS verified)
CE5-HF254-structure
CE5-HF254-sds
CE5-H82E0 Human Biotinylated Human CEACAM-5 / CD66e Protein, His,Avitag™ (MALS verified)
CE5-H82E0-structure
CE5-H82E0-sds
CE5-H5226 Human Human CEACAM-5 / CD66e Protein, His Tag (MALS verified)
CE5-H5226-structure
CE5-H5226-sds
ACRO Quality

Part of Bioactivity data

CHEK-ATP083-Cell-based assay
 CEACAM-5 FACS

Expression analysis of human CEACAM5 on HEK293/Human CEACAM5 Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human CEACAM5 Stable Cell Line or negative control cell using PE-labeled anti-human CEACAM5 antibody.

CE5-H82E0-SPR
 CEACAM-5 SPR

Anti-CEACAM-5 (labetuzumab) Antibody, Human IgG1 captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Biotinylated Human CEACAM-5, His,Avitag (Cat. No. CE5-H82E0) with an affinity constant of 12.1 nM as determined in a SPR assay (Biacore T200) (Routinely tested).

CE5-H5226-SPR
 CEACAM-5 SPR

Anti-CEACAM-5 (labetuzumab) Antibody, Human IgG1 captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Human CEACAM-5, His Tag (Cat. No. CE5-H5226) with an affinity constant of 8.41 nM as determined in a SPR assay (Biacore T200) (Routinely tested).

Synonym Name

CEACAM-5,CD66e,CEA,Meconium antigen 100

Background

Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) is also Carcinoembryonic antigen (CEA), Meconium antigen 100, CD antigen CD66e, CEACAM5 belongs to the immunoglobulin superfamily and CEA family. CEACAM5 contains seven Ig-like (immunoglobulin-like) domains. CEACAM5 is homodimer protein which binding of E.coli Dr adhesins leads to dissociation of the homodimer. CEACAM5 is cell surface glycoprotein that plays a role in cell adhesion and in intracellular signaling. CEACAM5 is receptor for E.coli Dr adhesins.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Tusamitamab Ravtansine SAR-408701; IBI-126 Phase 3 Clinical Immunogen Inc Esophageal Neoplasms; Stomach Neoplasms; Neoplasms; Pancreatic Neoplasms; Metastatic breast cancer; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma Details
SGM-101 SGM-101 Phase 3 Clinical Surgimab Sas Intestinal Neoplasms; Gastrointestinal Diseases; Rectal Neoplasms; Brain Diseases; Colonic Neoplasms; Pancreatic Neoplasms; Brain Neoplasms; Colorectal Neoplasms; Colonic Diseases; Brain metastases; Intestinal Diseases; Gastrointestinal Neoplasms Details
Cancer vaccine (BN ImmunoTherapeutics/National Cancer Institute) CVAC-301; CV-301 Phase 2 Clinical Therion Biologics Intestinal Neoplasms; Solid tumours; Cystadenocarcinoma; Ovarian Neoplasms; Pancreatic Neoplasms; Carcinoma, Transitional Cell; Urinary Bladder Neoplasms; Prostatic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Pancreatic Ductal; Melanoma; Neoplasm Metastasis; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung Details
NEO-201 NEO-201 Phase 2 Clinical Precision Biologics Inc, National Cancer Institute Squamous Cell Carcinoma of Head and Neck; Uterine Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms Details
Anti-CEA CAR T cell therapy (Shanghai GeneChem) Phase 2 Clinical Shanghai Genechem Co Ltd Liver Neoplasms; Colorectal Neoplasms Details
LM-24C5 LM-24C5 Phase 2 Clinical LaNova Medicines Ltd Solid tumours; Neoplasms Details
M-9140 M-9140; M9140 Phase 2 Clinical Merck KGaA, Darmstadt, Germany Solid tumours; Stomach Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung Details
MFE-23-CD3z T cell therapy (Cancer Research Technology) Phase 1 Clinical Cancer Research Technology Neoplasms Details
125-Iodine-labeled MFE-23 Phase 1 Clinical Cancer Research UK Neoplasms Details
anti-CEA CAR-T cell therapy (Sorrento/TNK therapeutics/Roger Williams Medical Center) Phase 1 Clinical Beth Israel Deaconess Medical Center Solid tumours; Liver Neoplasms; Pancreatic Neoplasms; Neoplasms; Neoplasm Metastasis; Adenocarcinoma Details
SGN-CEACAM5C PF-08046050; SAR445953; SGN-CEACAM5C; SAR-445953 Phase 1 Clinical Seagen Inc, Sanofi Solid tumours; Esophageal Neoplasms; Stomach Neoplasms; Small Cell Lung Carcinoma; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung Details
EBC-129 EBC-129; EBC129 Phase 1 Clinical Experimental Drug Development Centre Solid tumours Details
BGB-B167 BGB-B167 Phase 1 Clinical BeOne Medicines Ltd Solid tumours Details
GB-5012 GB-5012 Clinical Shanghai Genbase Biotechnology Co Ltd Colonic Neoplasms Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message